Hypothyroidism and mortality among dialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 4, 2013, Pages 593-601

  Rhee, Connie M ^a,b   Alexander, Erik K ^a,b   Bhan, Ishir ^b,c   Brunelli, Steven M ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE; THYROTROPIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; EUTHYROIDISM; FEMALE; HEMODIALYSIS PATIENT; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME;

AGED; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIAL SECURITY; THYROTROPIN;

EID: 84876021139     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06920712     Document Type: Article

References (49)

1. Chonchol M, Lippi G, Salvagno G, Zoppini G, Muggeo M, Targher G: Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. Clin J Am Soc Nephrol 3: 1296-1300, 2008.
2. Kaptein EM: Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev 17: 45-63, 1996.
3. Kaptein EM, Quion-Verde H, Chooljian CJ, Tang WW, Friedman PE, Rodriquez HJ, Massry SG: The thyroid in end-stage renal disease. Medicine (Baltimore) 67: 187-197, 1988.
4. Lo JC, Chertow GM, Go AS, Hsu CY: Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int 67: 1047-1052, 2005.
5. Ng YY, Wu SC, Lin HD, Hu FH, Hou CC, Chou YY, Chiu SM, Sun YH, Cho SS, Yang WC: Prevalence of clinical and subclinical thyroid disease in a peritoneal dialysis population. Perit Dial Int 32: 86-93, 2012.
6. Iervasi G, Molinaro S, Landi P, Taddei MC, Galli E, Mariani F, L'Abbate A, Pingitore A: Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med 167: 1526-1532, 2007.
7. McQuade C, Skugor M, Brennan DM, Hoar B, Stevenson C, Hoogwerf BJ: Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: A PreCIS database study. Thyroid 21: 837-843, 2011.
8. Molinaro S, Iervasi G, Lorenzoni V, Coceani M, Landi P, Srebot V, Mariani F, L'Abbate A, Pingitore A: Persistence of mortality risk in patients with acute cardiac diseases and mild thyroid dysfunction. Am J Med Sci 343: 65-70, 2012.
9. Cini G, Carpi A, Mechanick J, Cini L, Camici M, Galetta F, Giardino R, Russo MA, Iervasi G: Thyroid hormones and the cardiovascular system: Pathophysiology and interventions. Biomed Pharmacother 63: 742-753, 2009.
10. Klein I, Ojamaa K: Thyroid hormone and the cardiovascular system. N Engl J Med 344: 501-509, 2001.
11. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW: Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295: 1033-1041, 2006.
12. Waring AC, Harrison S, Samuels MH, Ensrud KE, LeBLanc ES, Hoffman AR, Orwoll E, Fink HA, Barrett-Connor E, Bauer DC; Osteoporotic Fractures in Men (MrOS) Study: Thyroid function andmortality in older men: A prospective study. J Clin Endocrinol Metab 97: 862-870, 2012.
13. Tatar E, Kircelli F, Asci G, Carrero JJ, Gungor O, Demirci MS, Ozbek SS, Ceylan N, Ozkahya M, Toz H, Ok E: Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients. Clin J Am Soc Nephrol 6: 2240-2246, 2011.
14. Tatar E, Sezis Demirci M, Kircelli F, Gungor O, Yaprak M, Asci G, Basci A, Ozkahya M, Ok E: The association between thyroid hormones and arterial stiffness in peritoneal dialysis patients. Int Urol Nephrol 44: 601-606, 2012.
15. Zoccali C, Benedetto F, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P, Malatino LS, Bonanno G, Seminara G: Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease. J Hypertens 24: 2039-2046, 2006.
16. Carrero JJ, Qureshi AR, Axelsson J, Yilmaz MI, Rehnmark S, Witt MR, Bárány P, Heimbürger O, Suliman ME, Alvestrand A, Lindholm B, Stenvinkel P: Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease. J InternMed 262: 690-701, 2007.
17. Meuwese CL, Dekker FW, Lindholm B, Qureshi AR, Heimburger O, Barany P, Stenvinkel P, Carrero JJ: Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol 7: 131-138, 2012.
18. Enia G, Panuccio V, Cutrupi S, Pizzini P, Tripepi G, Mallamaci F, Zoccali C: Subclinical hypothyroidism is linked to microinflammation and predicts death in continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 22: 538-544, 2007.
19. Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P: Low triiodothyronine and survival in end-stage renal disease. Kidney Int 70: 523-528, 2006.
20. Mariani LH, Berns JS: The renal manifestations of thyroid disease. J Am Soc Nephrol 23: 22-26, 2012.
21. Fatourechi V: Subclinical hypothyroidism: An update for primary care physicians. Mayo Clin Proc 84: 65-71, 2009.
22. Wiersinga WM: Hypothyroidism and myxedema coma. In: Endocrinology, Vol. 2, 5th Ed., edited by DeGroot LJ, Jameson JL, Philadelphia, Elsevier Saunders, 2006, pp 2081-2099.
23. Bhan I, Dubey A, Wolf M: Diagnosis andmanagement of mineral metabolism in CKD. J Gen Intern Med 25: 710-716, 2010.
24. Triant VA, Brown TT, Lee H, Grinspoon SK: Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab 93: 3499-3504, 2008.
25. Salvatore D, Davies TF, Schlumberger MJ, Hay ID, Larsen PR: Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In: Williams Textbook of Endocrinology, 12th Ed., edited by Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, Philadelphia, Elsevier Saunders, 2011, pp 327-361.
26. Yilmaz MI, Sonmez A, Karaman M, Ay SA, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C: Low triiodothyronine alters flow-mediated vasodilatation in advanced nondiabetic kidney disease. Am J Nephrol 33: 25-32, 2011.
27. Cooper D, Ladenson PW: The thyroid gland. In: Greenspan's Basic and Clinical Endocrinology, 9th Ed., edited by Gardner DG, Shoback D, New York, McGraw Hill Medical, 2011, pp 163-226.
28. Corssmit EP, Heyligenberg R, Endert E, Sauerwein HP, Romijn JA: Acute effects of interferon-alpha administration on thyroid hormone metabolism in healthy men. J Clin Endocrinol Metab 80: 3140-3144, 1995.
29. Nagaya T, Fujieda M, Otsuka G, Yang JP, Okamoto T, Seo H: A potential role of activated NF-kappa B in the pathogenesis of euthyroid sick syndrome. J Clin Invest 106: 393-402, 2000.
30. Stouthard JM, van der Poll T, Endert E, Bakker PJ, Veenhof CH, Sauerwein HP, Romijn JA: Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab 79: 1342-1346, 1994.
31. Van der Poll T, Romijn JA, Endert E, Borm JJ, Büller HR, Sauerwein HP: Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 261: E457-E465, 1991.
32. Lim VS: Thyroid function in patients with chronic renal failure. Am J Kidney Dis 38[Suppl 1]: S80-S84, 2001.
33. Weiss RE, Wu SY, Refetoff S: Diagnostic tests of the thyroid. In: Endocrinology, Vol. 2, 5th Ed., edited byDeGroot LJ, Jameson JL, Philadelphia, Elsevier Saunders, 2006, pp 1899-1961.
34. Carrero JJ, Stenvinkel P, Lindholm B: Endocrine aspects of chronic kidney disease. In: Taal: Brenner and Rector's The Kidney, 9th Ed., edited by Taal MW, Chertow GM, Marsden PA, Skorecki K, Yu AS, Brenner BM, Philadelphia, Elsevier Saunders, 2012, pp 2122-2137.
35. Spector DA, Davis PJ, Helderman JH, Bell B, Utiger RD: Thyroid function and metabolic state in chronic renal failure. Ann Intern Med 85: 724-730, 1976.
36. Morris MS, Bostom AG, Jacques PF, Selhub J, Rosenberg IH: Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey. Atherosclerosis 155: 195-200, 2001.
37. Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G: Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 86: 732-737, 2001.
38. Cooper DS, Biondi B: Subclinical thyroid disease. Lancet 379: 1142-1154, 2012.
39. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ: Subclinical thyroid disease: Scientific review and guidelines for diagnosis and management. JAMA 291: 228-238, 2004.
40. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG: Thyroid status, disability and cognitive function, and survival in old age. JAMA 292: 2591-2599, 2004.
41. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff E, Gussekloo J; Thyroid Studies Collaboration: Subclinical hypothyroidismand the risk of coronary heart disease andmortality. JAMA 304: 1365-1374, 2010.
42. Wheeler DC, Hayes R, Landray MJ, Baigent C: Cardiovascular aspects of kidney disease. In: Taal: Brenner and Rector's The Kidney, 9th Ed., edited by Taal MW, Chertow GM, Marsden PA, Skorecki K, Yu AS, Brenner BM, Philadelphia, Elsevier Saunders, 2012, pp 2060-2075.
43. US Renal Data System: USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2005.
44. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, Li Vosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR; Guidelines Committee, National Academy of Clinical Biochemistry: Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13: 3-126, 2003.
45. Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM, Segal RL; American Association of Clinical Endocrinologists: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 8: 457-469, 2002.
46. Wartofsky L, Dickey RA: The evidence for a narrower thyrotropin reference range is compelling. J Clin EndocrinolMetab 90: 5483-5488, 2005.
47. Surks MI, Hollowell JG: Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: Implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 92: 4575-4582, 2007.
48. Razvi S, Weaver JU, Butler TJ, Pearce SS: Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med 172: 811-817, 2012.
49. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 14: 3270-3277, 2003